BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3376955)

  • 1. Corporate influence on threshold limit values.
    Davis JM
    Am J Ind Med; 1988; 13(5):615. PubMed ID: 3376955
    [No Abstract]   [Full Text] [Related]  

  • 2. Corporate influence on threshold limit values by Castleman and Ziem.
    Frank AL
    Am J Ind Med; 1988; 13(5):607-8. PubMed ID: 3376951
    [No Abstract]   [Full Text] [Related]  

  • 3. TLVs--a personal opinion.
    Dror K
    Am J Ind Med; 1988; 13(5):617-8. PubMed ID: 3376956
    [No Abstract]   [Full Text] [Related]  

  • 4. Corporate influence on threshold limit values.
    Castleman BI; Ziem GE
    Am J Ind Med; 1988; 13(5):531-59. PubMed ID: 3287906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and use of threshold limit values with reference to "Corporate Influence on Threshold Limit Values" by Castleman and Ziem.
    Tsuchiya K
    Am J Ind Med; 1988; 14(2):215-6. PubMed ID: 3207108
    [No Abstract]   [Full Text] [Related]  

  • 6. TLVs--what now?
    Muir DC
    Am J Ind Med; 1988; 13(5):605-6. PubMed ID: 3376950
    [No Abstract]   [Full Text] [Related]  

  • 7. Credibility in the TLV process.
    Abrams HK
    Am J Ind Med; 1988; 13(5):609-10. PubMed ID: 3376952
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on the article by Castleman and Ziem.
    Djuric D
    Am J Ind Med; 1988; 13(5):613-4. PubMed ID: 3376954
    [No Abstract]   [Full Text] [Related]  

  • 9. Quis Custodiet ipsos Custodes (Juvenal, 98 A.D.).
    Lerman Y
    Am J Ind Med; 1988; 13(5):621-2. PubMed ID: 3376958
    [No Abstract]   [Full Text] [Related]  

  • 10. Standard setting.
    Duncan KP
    Am J Ind Med; 1988; 13(5):619-20. PubMed ID: 3376957
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to reconsider TLVs.
    Djerassi L
    Am J Ind Med; 1988; 13(5):611-2. PubMed ID: 3376953
    [No Abstract]   [Full Text] [Related]  

  • 12. Threshold limit values: a balanced report.
    Cox GV
    Am J Ind Med; 1988; 14(2):233-4. PubMed ID: 3207112
    [No Abstract]   [Full Text] [Related]  

  • 13. [The threshold limit values (author's transl)].
    Guillemin M
    Ther Umsch; 1975 Mar; 32(3):189-92. PubMed ID: 1179293
    [No Abstract]   [Full Text] [Related]  

  • 14. Threshold limit values: any alternative?
    Stokinger HE
    Am J Ind Med; 1988; 14(2):231-2. PubMed ID: 3207111
    [No Abstract]   [Full Text] [Related]  

  • 15. Threshold limit values: a timely look.
    Finklea JA
    Am J Ind Med; 1988; 14(2):211-2. PubMed ID: 3207106
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to "Corporate Influence on Threshold Limit Values".
    Elkins HB
    Am J Ind Med; 1988; 14(6):737-40. PubMed ID: 3232691
    [No Abstract]   [Full Text] [Related]  

  • 17. On "Corporate influence on threshold limit values" by Castleman and Ziem.
    Richter ED
    Am J Ind Med; 1988; 14(3):365-8. PubMed ID: 3189353
    [No Abstract]   [Full Text] [Related]  

  • 18. The nature and significance of the corporate influence on threshold limit values.
    Morton WE
    Am J Ind Med; 1988; 14(6):721-3. PubMed ID: 3232689
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Corporate influence on threshold limit values.
    Ahlberg R
    Am J Ind Med; 1989; 15(2):233. PubMed ID: 2729283
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Corporate influence on threshold limit values.
    Fraser DA
    Am J Ind Med; 1989; 15(2):235-6. PubMed ID: 2635878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.